Adiponectin levels decrease in parallel with the progression of insulin resistance and type 2 diabetes [25], and the antidiabetic drug thiazolidinedione increases adiponectin levels [26]. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.